The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
BOTOX Abbvie Pty Ltd
Product name
BOTOX
Sponsor
Accepted date
Jul-2024
Active ingredients
Botulinim toxin type a
Proposed indication
For the temporary improvement in the appearance of platysma prominence in adults.
Application type
C (new indication)
Publication date
Jul-2024